Choice
Journalistic ethics: an oxymoron?
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7329.0/i (Published 12 January 2002) Cite this as: BMJ 2002;324:i
Related articles
- Paper Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.71
- Editorial Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.59
- Education And Debate Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.103
- News Extra [these Stories Appear Only On The Web] Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.70/e
- News Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.70/f
- News Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.70
- News Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.70/a
- News Extra [these Stories Appear Only On The Web] Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.70/c
- News Extra [these Stories Appear Only On The Web] Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.70/d
See more
- Trump chooses Obamacare opponent to lead Health and Human ServicesBMJ November 30, 2016, 355 i6469; DOI: https://doi.org/10.1136/bmj.i6469
- Drug firms need to tackle affordabilityBMJ November 14, 2016, 355 i6096; DOI: https://doi.org/10.1136/bmj.i6096
- World Medical Association’s tainted president, Ketan DesaiBMJ November 10, 2016, 355 i5867; DOI: https://doi.org/10.1136/bmj.i5867
- Cancer drugs, survival, and ethicsBMJ November 09, 2016, 355 i5792; DOI: https://doi.org/10.1136/bmj.i5792
- WHO refers $29m Oxford research project to GMC for misconductBMJ November 07, 2016, 355 i5971; DOI: https://doi.org/10.1136/bmj.i5971